Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Equity Ratio: 2018-2025

Historic Equity Ratio for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to 0.80.

  • Arcturus Therapeutics Holdings' Equity Ratio rose 12.58% to 0.80 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.80, marking a year-over-year increase of 12.58%. This contributed to the annual value of 0.70 for FY2024, which is 7.98% up from last year.
  • As of Q3 2025, Arcturus Therapeutics Holdings' Equity Ratio stood at 0.80, which was up 6.46% from 0.75 recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' 5-year Equity Ratio high stood at 0.80 for Q3 2025, and its period low was 0.50 during Q3 2022.
  • Over the past 3 years, Arcturus Therapeutics Holdings' median Equity Ratio value was 0.70 (recorded in 2023), while the average stood at 0.69.
  • Examining YoY changes over the last 5 years, Arcturus Therapeutics Holdings' Equity Ratio showed a top increase of 210.95% in 2021 and a maximum decrease of 30.20% in 2021.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Equity Ratio (Quarterly) stood at 0.58 in 2021, then climbed by 3.31% to 0.60 in 2022, then rose by 8.07% to 0.65 in 2023, then increased by 7.98% to 0.70 in 2024, then increased by 12.58% to 0.80 in 2025.
  • Its Equity Ratio stands at 0.80 for Q3 2025, versus 0.75 for Q2 2025 and 0.70 for Q1 2025.